San Francisco startup Mave Health launched its novel brain-stimulating headset on March 18, 2026. The $495 device aims to enhance attention and elevate mood. It also promises to help regulate stress levels. The company seeks to offer a tangible way to measure mental well-being. This innovation targets individuals seeking improved cognitive and emotional states without a medical prescription.

The Mave Health headset employs neuromodulation technology. This approach uses targeted signals to influence brain activity. The device is designed for home use. It positions itself as a non-medical product. This avoids the need for FDA approval. The company believes this makes it accessible for wider consumer adoption.

Dhawal Jain founded Mave Health in 2023. He was driven by a personal tragedy. His flatmate’s fiancée died by suicide during the pandemic. This event highlighted a perceived lack of measurable progress in mental health care. Jain noted, “For somebody with depression who is spending a lot of time in therapy, progress is important.” He felt current methods lacked clear indicators of improvement.

The founders explored neuroscience. They consulted with experts in the field. Their research uncovered advancements in neuromodulation. These lab-based techniques were not yet available to the public. Mave Health collaborated with specialists. They worked with medical device and mental health professionals. This partnership informed the development and testing of their technology.

Mave Health’s device represents a new frontier in personal wellness technology. It offers a proactive approach to mental fitness. The company anticipates increased consumer interest in self-managed mental well-being tools. Future developments may explore further applications of neuromodulation for cognitive enhancement.